| Analysis | Metabolite Name | Measured Value | Units | subject type |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 1555 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 3840 | Peak area | Healthy control |
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 5129 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 8916 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 12744 | Peak area | Mild disease |
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | Healthy control | |
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | Mild disease | |
| Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | Severe disease |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|